新华制药
(000756)
| 流通市值：68.28亿 | | | 总市值：95.60亿 |
| 流通股本：4.93亿 | | | 总股本：6.90亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,304,573,051.73 | 1,245,022,873.47 | 1,158,318,911.44 | 996,332,270.24 |
| 应收票据及应收账款 | 1,243,904,408.83 | 909,119,667.2 | 981,148,228.56 | 1,033,782,443.1 |
| 其中：应收票据 | 43,597,218.77 | 40,915,665.41 | 9,731,035.63 | 11,120,887.78 |
| 应收账款 | 1,200,307,190.06 | 868,204,001.79 | 971,417,192.93 | 1,022,661,555.32 |
| 应收款项融资 | 134,441,914.43 | 210,085,781.65 | 107,579,010.69 | 265,906,217.22 |
| 预付款项 | 75,840,801.44 | 33,378,429.5 | 61,026,721.91 | 45,819,042.36 |
| 其他应收款合计 | 18,466,959.05 | 9,501,094.17 | 12,322,582.83 | 17,036,147.69 |
| 应收股利 | - | 1,495,894.4 | - | 8,182,200 |
| 存货 | 1,178,376,439.76 | 1,272,856,947.1 | 1,265,331,335.83 | 1,191,617,251.27 |
| 合同资产 | 439,963.12 | 439,963.12 | 657,211.26 | 678,211.26 |
| 其他流动资产 | 43,352,612.23 | 46,435,406.7 | 43,181,389.79 | 87,493,485.66 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,999,396,150.59 | 3,726,840,162.91 | 3,629,565,392.31 | 3,638,665,068.8 |
| 非流动资产: | | | | |
| 长期股权投资 | 57,970,175.83 | 58,730,419.65 | 58,789,469.55 | 59,906,504.83 |
| 其他权益工具投资 | 235,464,336.94 | 247,694,480.94 | 271,330,208.11 | 215,705,552.11 |
| 投资性房地产 | 30,995,572.08 | 31,797,104.69 | 32,594,764.39 | 33,411,820.38 |
| 固定资产 | 3,570,946,954.43 | 3,511,461,272.2 | 3,446,486,166.47 | 3,476,847,498.18 |
| 在建工程 | 733,330,632.98 | 781,095,104.92 | 772,568,081.63 | 671,137,450.24 |
| 使用权资产 | 2,837,829.28 | 3,086,649.43 | 1,655,952.41 | 3,386,775.98 |
| 无形资产 | 549,663,074.96 | 565,037,971.63 | 497,964,455.52 | 476,518,757.01 |
| 长期待摊费用 | 8,811,536.6 | 9,985,697.02 | 11,118,564.38 | 12,582,786.47 |
| 递延所得税资产 | 22,363,756.62 | 24,920,511.29 | 15,959,259.11 | 16,358,940.91 |
| 其他非流动资产 | 58,075,840.8 | 58,952,192.85 | 86,340,606.42 | 129,337,969.65 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,270,459,710.52 | 5,292,761,404.62 | 5,194,807,527.99 | 5,095,194,055.76 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,269,855,861.11 | 9,019,601,567.53 | 8,824,372,920.3 | 8,733,859,124.56 |
| 流动负债: | | | | |
| 短期借款 | 496,692,256.21 | 580,155,616.42 | 569,495,648.17 | 378,399,398.19 |
| 应付票据及应付账款 | 1,207,464,541.7 | 1,158,679,604.12 | 1,106,948,045.83 | 1,219,944,075.26 |
| 其中：应付票据 | 527,042,323.65 | 444,139,945.47 | 466,943,838.11 | 549,535,177.32 |
| 应付账款 | 680,422,218.05 | 714,539,658.65 | 640,004,207.72 | 670,408,897.94 |
| 合同负债 | 72,874,492.06 | 96,837,598.29 | 85,913,513.78 | 85,029,547.4 |
| 应付职工薪酬 | 54,342,952.47 | 73,108,770.91 | 44,556,875.97 | 45,175,159.34 |
| 应交税费 | 21,514,331.38 | 23,704,353.06 | 30,389,241.2 | 23,929,921.49 |
| 其他应付款合计 | 543,545,983.09 | 507,637,306.85 | 552,770,913.26 | 734,847,955.33 |
| 应付股利 | 14,292,599.53 | 14,292,599.53 | 14,292,599.53 | 184,894,508.28 |
| 一年内到期的非流动负债 | 798,239,495.64 | 313,667,062.97 | 296,197,899.94 | 110,571,244.26 |
| 其他流动负债 | 40,135,772.91 | 41,823,799.77 | 17,297,612.47 | 15,821,060.13 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 3,234,809,825.46 | 2,795,614,112.39 | 2,703,569,750.62 | 2,613,718,361.4 |
| 非流动负债: | | | | |
| 长期借款 | 398,340,739.2 | 771,540,739.2 | 791,040,739.2 | 912,190,889.2 |
| 租赁负债 | 1,165,628.99 | 1,105,117.4 | 391,884.16 | 1,164,135.29 |
| 长期应付款 | 22,500,000 | 21,500,000 | 21,500,000 | 21,500,000 |
| 递延收益 | 78,748,073.69 | 83,245,913.19 | 88,034,692.69 | 91,523,472.2 |
| 递延所得税负债 | 140,781,993.89 | 122,533,768.01 | 120,266,831.58 | 115,553,193.73 |
| 其他非流动负债 | 3,561,500 | 6,561,500 | 3,561,500 | 3,561,500 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 645,097,935.77 | 1,006,487,037.8 | 1,024,795,647.63 | 1,145,493,190.42 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 3,879,907,761.23 | 3,802,101,150.19 | 3,728,365,398.25 | 3,759,211,551.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 689,776,535 | 682,407,635 | 682,407,635 | 682,407,635 |
| 资本公积 | 1,195,981,380.41 | 1,144,555,095.24 | 1,131,062,026.76 | 1,122,731,950.76 |
| 其他综合收益 | 159,024,322.87 | 169,597,400.06 | 188,122,845.22 | 141,218,826.42 |
| 专项储备 | 9,881,288.37 | 6,267,199.72 | 6,997,065.49 | 6,505,475.15 |
| 盈余公积 | 438,326,844.39 | 438,326,844.39 | 400,960,654.39 | 400,960,654.39 |
| 未分配利润 | 2,662,529,607.61 | 2,550,434,350.37 | 2,461,856,744.96 | 2,400,241,402.85 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,155,519,978.65 | 4,991,588,524.78 | 4,871,406,971.82 | 4,754,065,944.57 |
| 少数股东权益 | 234,428,121.23 | 225,911,892.56 | 224,600,550.23 | 220,581,628.17 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,389,948,099.88 | 5,217,500,417.34 | 5,096,007,522.05 | 4,974,647,572.74 |
| 负债和股东权益合计 | 9,269,855,861.11 | 9,019,601,567.53 | 8,824,372,920.3 | 8,733,859,124.56 |
| 公告日期 | 2025-04-29 | 2025-03-31 | 2024-10-30 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |